Digital Pathology Market Product Overview and Share Forecasted to 2026 with Top Players Ventana Medical Systems, Definiens AG, Omnyx, Hamamatsu Photonics K.K, Corista, GE Healthcare, Inspirata

Digital pathology plays a major role in advanced healthcare as it converts analog microscopic images into digital images. Digital pathology is a potential method for diagnosis of pathological condition of cancer and other diseases.

The global digital pathology market size was valued at US$ 335.0 million in 2017, and is expected to exhibit a CAGR of 12.5 % over the forecast period (2018 – 2026).
Digital pathology is a technology, which enables management and interpretation of pathological conditions from a simple slide to computer screen for better analysis and diagnosis. High prevalence of cancer is expected to drive the market growth. According to the World Health Organization (WHO), September 2018 Factsheet, in 2018, cancer was the second leading cause of death worldwide and around 9.6 million deaths were recorded due to the disease.

Moreover, increasing incidences of infectious diseases such as sexually transmitted diseases, malaria, and other diseases is also propelling growth of the digital pathology market over the forecast period. According to the World Health Organization (WHO), July 2018 Factsheet, around 71 million people have chronic hepatitis C infection worldwide and around 3,99,000 deaths occur annually from hepatitis C mostly due to cirrhosis and hepatocellular carcinoma. However, factors such as high cost associated with diagnostic systems, stringent regulatory requirements, sampling errors, lack of standard guidelines, reimbursement status, and reproducibility and reliability concerns are expected to hinder the market growth.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/379

North America holds dominant position in the global digital pathology market, owing to increasing government initiatives for diagnostics pathology and laboratory testing. For instance, in October 2015, The Centers for Global Health (CGH) partnered with the World Bank to support the East Africa Public Health Laboratory Networking Project. CGH also supports several programs for improving access to diagnostic pathology and laboratory medicines worldwide. Moreover, increasing prevalence of cancer in this region is also expected to bolster the market growth over the forecast period. For instance, according to the International Agency for Research on Cancer (IARC), in 2018, around 2,378,785 new cases of cancer were recorded in North America.

Key players in the market are focused on receiving regulatory approvals for novel products to enhance their market share, which in turn is expected to boost the market growth. For instance, in April 2017, Philips IntelliSite Pathology Solution developed by Philips Digital Pathology Solutions received the U.S. Food and Drug Administration (FDA) approval for primary diagnosis in surgical pathology.

Key Players

Major players operating in the global digital pathology market include, Ventana Medical Systems, Inc., Definiens AG, Omnyx, LLC, Hamamatsu Photonics K.K, Corista LLC, GE Healthcare, Inspirata Co, Philips Healthcare, 3D-Histech Ltd., Olympus Corporation, Sectra AB, Leica Biosystems, Apollo Enterprise Imaging, Visiopharm, Huron Digital Pathology, Indica Labs, and Perkin Elmer, Inc.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/379

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.